US 11793819
Natural combination hormone replacement formulations and therapies
granted A61KA61K31/565A61K31/57
Quick answer
US patent 11793819 (Natural combination hormone replacement formulations and therapies) held by Compass Therapeutics LLC expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/565, A61K31/57, A61K47/10, A61K47/14